Noxopharm Limited (ASX:NOX)

Noxopharm Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.55	2.32	3.01	14.01	26.8
Cash & Short-Term Investments	1.55	2.32	3.01	14.01	26.8
Cash Growth	-33.01%	-22.89%	-78.53%	-47.71%	277.40%
Accounts Receivable	-	-	-	0.01	0
Other Receivables	2.95	2.4	6.08	5.21	5.79
Receivables	2.95	2.4	6.08	5.21	5.8
Inventory	-	-	-	1.15	0.31
Prepaid Expenses	0.08	0.04	0.07	0.46	0.07
Total Current Assets	4.58	4.77	9.16	20.83	32.97
Property, Plant & Equipment	0	0.01	0.01	0.22	0.48
Long-Term Investments	-	2.01	0.96	5.42	14.27
Other Long-Term Assets	-	-	-	0.12	0.12
Total Assets	4.58	6.78	10.13	26.59	47.85
Accounts Payable	0.45	0.65	0.45	0.81	0.96
Accrued Expenses	0.93	0.51	0.41	1.14	5.53
Short-Term Debt	2.48	-	-	-	-
Current Portion of Leases	-	-	-	0.16	0.23
Other Current Liabilities	0.01	0.08	0.1	0.17	0.08
Total Current Liabilities	3.87	1.25	0.96	2.28	6.81
Long-Term Leases	-	-	-	-	0.12
Pension & Post-Retirement Benefits	0.02	0.04	0.09	0.19	0.15
Total Liabilities	3.89	1.29	1.06	2.48	7.08
Common Stock	74.64	74.64	74.64	74.64	72.62
Retained Earnings	-74.65	-70.07	-72.06	-58.8	-40.33
Comprehensive Income & Other	0.7	0.93	6.5	8.29	8.49
Total Common Equity	0.69	5.5	9.07	24.12	40.78
Shareholders' Equity	0.69	5.5	9.07	24.12	40.78
Total Liabilities & Equity	4.58	6.78	10.13	26.59	47.85
Total Debt	2.48	-	-	0.16	0.35
Net Cash (Debt)	-0.92	2.32	3.01	13.85	26.45
Net Cash Growth	-	-22.89%	-78.28%	-47.63%	1159.30%
Net Cash Per Share	-0.00	0.01	0.01	0.05	0.10
Filing Date Shares Outstanding	292.24	292.24	292.24	292.24	288.23
Total Common Shares Outstanding	292.24	292.24	292.24	292.24	288.22
Working Capital	0.71	3.52	8.2	18.55	26.17
Book Value Per Share	0.00	0.02	0.03	0.08	0.14
Tangible Book Value	0.69	5.5	9.07	24.12	40.78
Tangible Book Value Per Share	0.00	0.02	0.03	0.08	0.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.